Does hormone therapy exacerbate the adverse effects of radiotherapy in men with prostate cancer? A quality of life study

Journal of Urology

Volumn 185, Issue 5, 2011, Pages 1674-1680

  Grant, Jonathan D ^a   Litwin, Mark S ^a   Kwan, Lorna ^a   Lee, Steve P ^a   Steinberg, Michael L ^a   King, Christopher R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

androgen antagonists; prostate; prostatic neoplasms; quality of life; radiotherapy

Indexed keywords

BICALUTAMIDE; LEUPRORELIN; PROSTATE SPECIFIC ANTIGEN; TAMSULOSIN;

ADULT; AGED; ALCOHOL ABUSE; ANDROGEN DEPRIVATION THERAPY; ARTICLE; BRACHYTHERAPY; CANCER STAGING; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; ERECTILE DYSFUNCTION; ETHNIC DIFFERENCE; EXTERNAL BEAM RADIOTHERAPY; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE ADENOCARCINOMA; QUALITY OF LIFE; RISK BENEFIT ANALYSIS; SEXUAL FUNCTION; SINGLE MAN; TREATMENT DURATION; URINARY TRACT DISEASE;

ADENOCARCINOMA; AGED; ANDROGEN ANTAGONISTS; BRACHYTHERAPY; CHI-SQUARE DISTRIBUTION; COMBINED MODALITY THERAPY; HUMANS; MALE; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; QUALITY OF LIFE; QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 79953779805     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2010.12.092     Document Type: Article

References (30)

1. A. Jemal, R. Siegel, and E. Ward Cancer statistics, 2009 CA Cancer J Clin 59 2009 225
2. M.D. Shelley, S. Kumar, and T. Wilt A systematic review and meta-analysis of randomised trials of neo-adjuvant hormone therapy for localised and locally advanced prostate carcinoma Cancer Treat Rev 35 2009 9
3. A.V. D'Amico, M.H. Chen, and A.A. Renshaw Androgen suppression and radiation vs radiation alone for prostate cancer: a randomized trial JAMA 299 2008 289
4. M. Bolla, D. Gonzalez, and P. Warde Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin N Engl J Med 337 1997 295
5. H. Isbarn, L. Boccon-Gibod, and P.R. Carroll Androgen deprivation therapy for the treatment of prostate cancer: consider both benefits and risks Eur Urol 55 2009 62
6. M.G. Sanda, R.L. Dunn, and J. Michalski Quality of life and satisfaction with outcome among prostate-cancer survivors N Engl J Med 358 2008 1250
7. M.S. Litwin, J.L. Gore, and L. Kwan Quality of life after surgery, external beam irradiation, or brachytherapy for early-stage prostate cancer Cancer 109 2007 2239
8. C.A. McHorney, J.E. Ware Jr, and A.E. Raczek The MOS 36-Item Short-Form Health Survey (SF-36): II Psychometric and clinical tests of validity in measuring physical and mental health constructs Med Care 31 1993 247
9. M.S. Litwin, R.D. Hays, and A. Fink The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure Med Care 36 1998 1002
10. M.J. Barry, F.J. Fowler Jr, and M.P. O'Leary The American Urological Association symptom index for benign prostatic hyperplasia The Measurement Committee of the American Urological Association J Urol 148 1992 1549
11. D.T. Eton, S.J. Lepore, and V.S. Helgeson Early quality of life in patients with localized prostate carcinoma: an examination of treatment-related, demographic, and psychosocial factors Cancer 92 2001 1451
12. R. Jayadevappa, J.C. Johnson, and S. Chhatre Ethnic variation in return to baseline values of patient-reported outcomes in older prostate cancer patients Cancer 109 2007 2229
13. E.M. Roeloffzen, I.M. Lips, and M.P. van Gellekom Health-related quality of life up to six years after (125)I brachytherapy for early-stage prostate cancer Int J Radiat Oncol Biol Phys 76 2010 1054
14. M.J. Zelefsky, D. Cowen, and Z. Fuks Long term tolerance of high dose three-dimensional conformal radiotherapy in patients with localized prostate carcinoma Cancer 85 1999 2460
15. M.V. Pilepich, J.M. Krall, and M. al-Sarraf Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the Radiation Therapy Oncology Group Urology 45 1995 616
16. B.K. Hollenbeck, J.T. Wei, and M.G. Sanda Neoadjuvant hormonal therapy impairs sexual outcome among younger men who undergo external beam radiotherapy for localized prostate cancer Urology 63 2004 946
17. C.T. Chen, R.K. Valicenti, and J. Lu Does hormonal therapy influence sexual function in men receiving 3D conformal radiation therapy for prostate cancer? Int J Radiat Oncol Biol Phys 50 2001 591
18. L. Potters, T. Torre, and P.A. Fearn Potency after permanent prostate brachytherapy for localized prostate cancer Int J Radiat Oncol Biol Phys 50 2001 1235
19. B.K. Hollenbeck, R.L. Dunn, and J.T. Wei Neoadjuvant hormonal therapy and older age are associated with adverse sexual health-related quality-of-life outcome after prostate brachytherapy Urology 59 2002 480
20. M. Pinkawa, K. Fischedick, and B. Gagel Association of neoadjuvant hormonal therapy with adverse health-related quality of life after permanent iodine-125 brachytherapy for localized prostate cancer Urology 68 2006 104
21. J.L. Speight, E.P. Elkin, and D.J. Pasta Longitudinal assessment of changes in sexual function and bother in patients treated with external beam radiotherapy or brachytherapy, with and without neoadjuvant androgen ablation: data from CaPSURE Int J Radiat Oncol Biol Phys 60 2004 1066
22. E. Bria, F. Cuppone, and D. Giannarelli Does hormone treatment added to radiotherapy improve outcome in locally advanced prostate cancer?: meta-analysis of randomized trials Cancer 115 2009 3446
23. A.B. Jani, and J. Gratzle Late radiotherapy toxicity after prostate cancer treatment: influence of hormonal therapy Urology 66 2005 566
24. S.T. Peeters, W.D. Heemsbergen, and W.L. van Putten Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy Int J Radiat Oncol Biol Phys 61 2005 1019
25. M. Liu, T. Pickles, and A. Agranovich Impact of neoadjuvant androgen ablation and other factors on late toxicity after external beam prostate radiotherapy Int J Radiat Oncol Biol Phys 58 2004 59
26. H.W. Herr, and M. O'Sullivan Quality of life of asymptomatic men with nonmetastatic prostate cancer on androgen deprivation therapy J Urol 163 2000 1743
27. H.J. Green, K.I. Pakenham, and B.C. Headley Quality of life compared during pharmacological treatments and clinical monitoring for non-localized prostate cancer: a randomized controlled trial BJU Int 93 2004 975
28. A.L. Potosky, B.B. Reeve, and L.X. Clegg Quality of life following localized prostate cancer treated initially with androgen deprivation therapy or no therapy J Natl Cancer Inst 94 2002 430
29. D.P. Lubeck, G.D. Grossfeld, and P.R. Carroll The effect of androgen deprivation therapy on health-related quality of life in men with prostate cancer Urology 58 2001 94
30. G.S. Merrick, W.M. Butler, and K.E. Wallner Erectile function after prostate brachytherapy Int J Radiat Oncol Biol Phys 62 2005 437